JANASHAKTHI INSURANCE PLC Financial Summary
JINS.N0000 · JANASHAKTHI INSURANCE PLC · Insurance · 2026-08-15
JANASHAKTHI INSURANCE PLC Financial Summary and Investment Analysis
Executive Overview
JANASHAKTHI INSURANCE PLC has operated exclusively in life insurance since 2015, serving individual and corporate customers. At end-2025 it operated through 76 branches with 16 life-insurance solutions and 456 employees.
Periods covered: Q3 2023-Q2 2026, including audited CY2025 financial statements and unaudited Q1-Q2 2026 interim statements.
The business is experiencing strong premium growth but sharply weaker near-term earnings quality. CY2025 Gross Written Premium (GWP) rose 31.1% to LKR 8.650 Bn, although PAT declined 23.2% to LKR 3.466 Bn as extraordinary investment returns normalised and expenses increased. Capital remained strong with a 284% CAR versus the 120% regulatory minimum, while the insurer held an A- (IFS), Stable rating.
This divergence intensified in H1 2026: GWP increased 35.6% YoY to LKR 5.112 Bn, but PAT collapsed 90.2% to LKR 129.6 Mn. Q2 2026 PAT was only LKR 15.9 Mn, principally reflecting higher claims/expenses and losses from the First Capital Holdings PLC associate investment.
Financial Performance
Revenue and Profitability Trends
*LKR Mn. For an insurer, conventional gross profit/GP margin is not meaningful; Net Income and PAT margin are used instead.*
| Period | GWP | Net Income | PAT | PAT Margin |
|---|---|---|---|---|
| Q3 2023 | 1,251.5 | 5,569.4 | 1,045.1 | 18.8% |
| Q4 2023 | 1,286.3 | 2,309.1 | 2,106.9 | 91.2% |
| Q1 2024 | 1,231.2 | 2,757.0 | 486.2 | 17.6% |
| Q2 2024 | 1,729.3 | 2,737.8 | 291.5 | 10.6% |
| Q3 2024 | 1,932.0 | 2,667.3 | 23.1 | 0.9% |
| Q4 2024 | 1,703.6 | 5,056.9 | 3,711.3 | 73.4% |
| Q1 2025 | 1,830.5 | 2,687.3 | 292.1 | 10.9% |
| Q2 2025 | 1,938.7 | 3,293.5 | 1,026.1 | 31.2% |
| Q3 2025 | 2,372.8 | 4,303.8 | 1,475.6 | 34.3% |
| Q4 2025 | 2,508.2 | 3,469.0 | 672.3 | 19.4% |
| Q1 2026 | 2,596.8 | 3,295.0 | 113.7 | 3.4% |
| Q2 2026 | 2,514.9 | 3,027.6 | 15.9 | 0.5% |
Q4 figures use later audited/restated information where it supersedes earlier unaudited Q4 disclosures.
CY2025 GWP rose from LKR 6.596 Bn to LKR 8.650 Bn, giving a strong 37.4% GWP CAGR from CY2023-CY2025. However, Net Income increased only 3.7% to LKR 13.754 Bn and PAT fell from LKR 4.512 Bn to LKR 3.466 Bn.
Other revenue declined from LKR 6.919 Bn to LKR 5.380 Bn, including lower investment income and realised gains. Associate profit declined to LKR 939.2 Mn from LKR 1.332 Bn. Meanwhile, acquisition costs increased 52%, operating/administrative expenses rose 21.5%, and the increase in the Life Insurance Fund reached LKR 2.413 Bn.
Q2 2026 highlights the current earnings pressure: GWP grew 29.7% YoY, but PAT dropped 98.4%. Net claims rose 55.5%, operating expenses 26.0%, and the associate contribution changed from a LKR 532.1 Mn profit to a LKR 168.5 Mn loss.
Balance Sheet Analysis
| LKR Mn | 2024-12-31 | 2025-12-31 | 2026-06-30 |
|---|---|---|---|
| Total Assets | 37,896.8 | 40,366.3 | 41,144.1 |
| Financial Investments | 29,022.1 | 31,507.5 | 31,941.1 |
| Investment in Associate | 4,572.0 | 4,140.2 | 3,851.3 |
| Life Insurance Liability | 16,031.4 | 18,482.3 | 19,607.9 |
| Long-Term Borrowings | 2,163.6 | 1,622.5 | 1,351.6 |
| Total Equity | 16,902.6 | 16,644.0 | 16,770.5 |
| Cash | 456.9 | 340.7 | 790.5 |
Assets expanded 6.5% during 2025 and another 1.9% in H1 2026. Financial investments represented approximately 78% of 2025 assets, making investment performance an important earnings driver.
Life insurance liabilities grew 15.3% during 2025 and another 6.1% by 2026-06-30. Long-term borrowings declined consistently; debt/equity improved from approximately 9.7% at 2025-12-31 to 8.1% at 2026-06-30.
A conventional current ratio cannot be reliably calculated because the insurer does not present its balance sheet using standard current/non-current classifications.
Cash Flow Analysis
| LKR Mn | CY2024 | CY2025 | H1 2025 | H1 2026 |
|---|---|---|---|---|
| Operating Cash Flow | 4,478.0 | 4,603.4 | 3,712.6 | 1,579.1 |
| Investing Cash Flow | 272.0 | (637.2) | (3,151.9) | (785.1) |
| Financing Cash Flow | (4,486.9) | (4,140.5) | (387.3) | (353.6) |
CY2025 operating cash generation remained strong. After approximately LKR 308.9 Mn of PPE/intangible purchases, estimated free cash flow was LKR 4.295 Bn.
Cash dividends paid were LKR 3.398 Bn, approximately 98% of CY2025 PAT but covered about 1.26x by estimated free cash flow.
H1 2026 operating cash flow fell 57.5% YoY, although cash increased to LKR 790.5 Mn because investment and financing outflows were substantially lower.
Key Financial Ratios and Growth Indicators
| Indicator | Result |
|---|---|
| CY2025 GWP Growth | 31.1% |
| CY2025 PAT Growth | (23.2%) |
| CY2023-CY2025 GWP CAGR | 37.4% |
| CY2025 CAR | 284% |
| Regulatory Minimum CAR | 120% |
| CY2025 EPS | LKR 15.30 pre-split |
| Equivalent post-split EPS | LKR 5.10 |
| 2026 H1 Restated EPS | LKR 0.19 |
| 2026-06-30 Net Assets/Share | LKR 24.68 |
| CY2025 reported P/E | 8.5x |
The annual report contains inconsistent ROE disclosures: financial highlights indicate 28%, while the Financial Capital Report states 21%. This should therefore be interpreted cautiously.
Economic and Market Context
Management describes Sri Lanka as recovering from the 2022 crisis, supported by reforms and debt restructuring. Low inflation of approximately 2.1% and improved macroeconomic stability supported household purchasing power and policy retention.
Conversely, declining and subsequently stabilising interest rates reduced the exceptional fixed-income returns previously enjoyed by insurers. This explains why very strong premium growth has not translated proportionately into investment income or earnings.
Regular New Business grew 61% in 2025, while the Regular Life Renewal portfolio grew 17%, indicating both acquisition momentum and improved retention.
Future Potential and Outlook
Management intends to expand revenue through products aligned with consumer purchasing capacity, penetrate underserved markets, increase automation, embed AI in underwriting and claims, maintain disciplined ALM and strengthen customer engagement.
H1 2026 premium composition remains encouraging: First Year Premium reached LKR 3.554 Bn versus LKR 2.515 Bn, while renewal premium increased to LKR 1.557 Bn from LKR 1.254 Bn.
A major structural change is the adoption of SLFRS 17 and SLFRS 9. Q1-Q3 2026 receive temporary alternative-treatment relief, but Q4 and annual 2026 financial statements must comply fully, including comparative 2025 information. This will materially change insurance liability measurement, profit emergence, financial-asset classification and presentation.
Risks and Challenges
- Investment/associate volatility: First Capital Holdings moved from a major profit contributor to a LKR 288.9 Mn H1 2026 associate loss.
- Claims pressure: medical-related claims frequency and claims ratios have increased.
- Expense growth: acquisition and administrative costs are rising alongside business expansion.
- Interest-rate risk: lower yields constrain investment profitability.
- Accounting transition: SLFRS 17/9 may materially alter reported equity and earnings patterns.
- Dividend sustainability: CY2025 distributions consumed almost all reported PAT; continuation at similar levels would require stronger earnings/cash generation.
- Concentration: investment assets and the controlling shareholder position both create concentration considerations.
- Additional risks include underwriting, reserving, lapses, sovereign exposure, regulatory changes and macroeconomic/political developments.
Shareholder and Corporate Information
A 1:3 share subdivision was completed in April 2026, increasing issued shares from 226,526,153 to 679,578,459 without changing stated capital.
At 2026-06-30, Janashakthi Limited held 74.24%, First Capital Limited 5.77% and Y.S.H.I. Silva 3.21%. Public shareholding remained 19.97%, represented by 8,717 shareholders. Directors reported no direct shareholdings.
The share closed CY2025 at LKR 129.50 before subdivision, equivalent to approximately LKR 43.17 post-split. It closed 2026-06-30 at LKR 45.00 and 2026-08-14 at LKR 43.50. The latest 90-session range was LKR 40.00-LKR 56.00.
Market capitalisation was LKR 30.581 Bn at 2026-06-30, with float-adjusted market capitalisation of LKR 6.108 Bn.
Investment Decision Indicators
Strengths
- Exceptional and accelerating premium growth.
- Strong new-business and renewal momentum.
- 284% CAR provides substantial regulatory capital headroom.
- Strong operating cash generation and declining borrowings.
- Established distribution network and growing digital capabilities.
Weaknesses
- Earnings depend heavily on investment-market and associate performance.
- H1 2026 PAT deterioration is severe despite strong GWP.
- Claims and operating costs are increasing.
- Equity growth has been constrained by very large dividend distributions.
Opportunities
- Further market-share gains in life insurance.
- Underpenetrated customer segments.
- AI/digitalisation-driven efficiency and underwriting improvement.
- Recovering domestic economy and improving policy retention.
Threats
- Continued losses from the associate investment.
- Claims inflation/frequency and weaker investment yields.
- SLFRS 17/9 transition uncertainty.
- Regulatory, sovereign, market and interest-rate volatility.
Overall assessment: JANASHAKTHI INSURANCE PLC enters 2026 with strong solvency, rapid premium expansion, improving leverage and a sizeable investment base. The principal issue is no longer top-line growth but conversion of premium growth into sustainable earnings. H1 2026 demonstrates that associate losses, claims and expenses can almost eliminate quarterly profit. The key indicators to monitor are underwriting profitability, claims growth, First Capital's contribution, operating-cost growth, CAR after SLFRS 17 implementation, operating cash flow and dividend policy. No BUY/SELL/HOLD conclusion is made.